… HLA and KIR. The central element of this project is to apply next generation sequencing methods and a validated … management of many of these diseases, we are still missing complete and coherent models of pathogenesis and as a … the same variants show association with multiple traits, whereas in other cases, the associations are mediated by …

… specializing in Parkinson’s.   Denial, Depression, then Community   “I didn’t even know what Parkinson’s was,” Toney … forward to events like MJFF’s PDIQ St. Louis in 2026 , where she hopes to meet others in the community and continue … how you can get involved in BLAAC PD call 1-866-274-1912 or visit blaacpd.org. Dillon Woodward Patient Engagement …

… disease. Often, she spends hours working in her studio to create stained glass mosaics . But on other days, she … Maguire experiences the roller coaster of “on/off periods” common to many people taking Parkinson’s medication. Every … device no larger than a credit card, made up of a reservoir where the drug is stored, and a series of painless …

… Laboratory experiments are not unlike cooking, when the end result … share data and which ones worked the best. Already, MJFF’s “community validation model” for sharing LRRK2 antibodies is … that they can use these antibodies to now begin to look at where, and how, in the human brain mutations in the gene …

… testing and approval processes and therefore are attractive to patients and disease foundations. However, the lack of commercial incentive for drug repurposing makes the practice … repurposing news from the Foundation.  Maggie Kuhl Vice President Patient Engagement …

… Editor's Note: For more Foundation news, research updates and … scope of these investigations, going wide to gather an unprecedented amount of data from thousands of people and deep … to continued progress. But no technology can get us where we need to go without you -- patients and families …